U.S. IT Consulting Industry Analysis

Industry Valuation and Performance

Has the U.S. IT Consulting Industry valuation changed over the past few years?

Date	Market Cap	Revenue	Earnings	PE	Absolute PE	PS
Mon, 29 Jun 2026	US$376.3b	US$211.6b	US$21.3b	11.9x	17.7x	1.8x
Wed, 27 May 2026	US$399.1b	US$210.6b	US$21.1b	15.2x	18.9x	1.9x
Fri, 24 Apr 2026	US$423.9b	US$215.1b	US$22.7b	14.3x	18.7x	2x
Sun, 22 Mar 2026	US$422.6b	US$215.1b	US$22.6b	15.8x	18.7x	2x
Tue, 17 Feb 2026	US$461.4b	US$213.6b	US$22.5b	18.1x	20.5x	2.2x
Thu, 15 Jan 2026	US$553.8b	US$211.0b	US$20.0b	23.3x	27.7x	2.6x
Sat, 13 Dec 2025	US$591.2b	US$240.5b	US$21.3b	22.6x	27.8x	2.5x
Mon, 10 Nov 2025	US$565.1b	US$240.3b	US$21.0b	19.3x	26.9x	2.4x
Wed, 08 Oct 2025	US$551.9b	US$238.7b	US$19.6b	20.8x	28.2x	2.3x
Fri, 05 Sep 2025	US$481.8b	US$207.0b	US$18.9b	21.9x	25.5x	2.3x
Sun, 03 Aug 2025	US$494.5b	US$206.8b	US$19.1b	21.3x	25.9x	2.4x
Tue, 01 Jul 2025	US$564.2b	US$205.3b	US$18.7b	24.7x	30.2x	2.7x
Thu, 29 May 2025	US$557.5b	US$204.0b	US$18.4b	26.7x	30.3x	2.7x
Sat, 26 Apr 2025	US$500.9b	US$203.4b	US$17.9b	28.6x	27.9x	2.5x
Mon, 24 Mar 2025	US$534.5b	US$203.4b	US$18.4b	32.3x	29x	2.6x
Wed, 19 Feb 2025	US$630.4b	US$202.5b	US$18.2b	40.4x	34.7x	3.1x
Fri, 17 Jan 2025	US$556.9b	US$202.4b	US$18.2b	34.7x	30.6x	2.8x
Sun, 15 Dec 2024	US$573.4b	US$201.1b	US$17.8b	39.7x	32.1x	2.9x
Tue, 12 Nov 2024	US$559.0b	US$202.0b	US$17.7b	41.9x	31.5x	2.8x
Thu, 10 Oct 2024	US$565.5b	US$202.2b	US$19.4b	41.4x	29.1x	2.8x
Sat, 07 Sep 2024	US$525.8b	US$202.6b	US$19.2b	32.1x	27.4x	2.6x
Mon, 05 Aug 2024	US$503.1b	US$202.8b	US$19.3b	29.1x	26.1x	2.5x
Wed, 03 Jul 2024	US$468.3b	US$203.1b	US$18.8b	30.6x	24.9x	2.3x
Fri, 31 May 2024	US$443.7b	US$203.3b	US$18.9b	28.3x	23.5x	2.2x
Sun, 28 Apr 2024	US$461.8b	US$199.4b	US$17.8b	20.4x	26x	2.3x
Tue, 26 Mar 2024	US$511.9b	US$199.1b	US$17.1b	21.5x	29.9x	2.6x
Thu, 22 Feb 2024	US$525.2b	US$199.3b	US$17.0b	21.9x	30.9x	2.6x
Sat, 20 Jan 2024	US$518.3b	US$199.8b	US$16.4b	20.4x	31.5x	2.6x
Mon, 18 Dec 2023	US$495.1b	US$199.4b	US$16.3b	19.2x	30.3x	2.5x
Wed, 15 Nov 2023	US$447.4b	US$199.3b	US$16.3b	20.1x	27.4x	2.2x
Fri, 13 Oct 2023	US$442.4b	US$198.8b	US$11.4b	20.1x	38.9x	2.2x
Sun, 10 Sep 2023	US$456.9b	US$198.3b	US$11.7b	20.4x	39.1x	2.3x
Tue, 08 Aug 2023	US$446.1b	US$198.4b	US$11.6b	21.8x	38.4x	2.2x
Thu, 06 Jul 2023	US$432.0b	US$200.6b	US$11.3b	23.8x	38.2x	2.2x

Current Industry PE

Investors are pessimistic on the American IT Consulting and Other Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.

The industry is trading at a PE ratio of 17.7x which is lower than its 3-year average PE of 28.4x.

The 3-year average PS ratio of 2.4x is higher than the industry's current PS ratio of 1.8x.

Past Earnings Growth

The earnings for companies in the IT Consulting and Other Services industry have grown 23% per year over the last three years, while revenues have remained mostly flat.
This means that companies overall are more efficiently conducting business since profits are increasing while sales have been flat.

Industry Comparison

How does U.S. IT Consulting compare with similar industries?


US Market	-2.52%
Tech	-5.78%
IT	2.41%
IT Consulting	5.65%
Internet Services and Infrastructure	0.19%
Data Processing Services	-0.90%

Industry PEThere are no additional sub-industries under this industry.

Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

Company	Last Price	7D	1Y	Valuation
IBM International Business Machines	US$271.63	7.7% +US$18.2b	-7.9%	PE23.8x
ACN Accenture	US$128.98	3.3% +US$2.5b	-56.8%	PE10.1x
IT Gartner	US$134.96	7.3% +US$618.0m	-66.6%	PE12.2x
EPAM EPAM Systems	US$80.68	6.1% +US$242.4m	-54.4%	PE10.9x
KD Kyndryl Holdings	US$11.32	6.6% +US$153.9m	-73.0%	PE12.6x

Brand Engagement Network, Grupo Skye, and Knobloch Information Group Advance Skye Salud to Phase 2 Clinical Evaluation in Mexico

Brand Engagement Network, Grupo Skye, and KNOBLOCH Information Group advanced Skye Salud to Phase 2 of its clinical evaluation program in Mexico. Skye Salud is an AI-powered medical evidence platform that leverages trusted medical literature, clinical guidelines, and other authoritative sources to support evidence-based clinical information retrieval. The initiative combines Brand Engagement Network's enterprise-grade AI capabilities, Grupo Skye's leadership in AI innovation across Latin America, and KNOBLOCH Information Group's longstanding presence and trusted relationships within Mexico's healthcare community. The organizations are evaluating how AI-powered access to trusted medical evidence may help improve access to clinical information across healthcare settings in Mexico and Latin America. The Phase 2 evaluation follows the successful completion of Phase 1 rheumatology testing conducted in a controlled evaluation environment. The initial evaluation assessed platform performance across specialty-specific clinical scenarios, evidence traceability, response quality and source transparency. The Phase 2 evaluation will expand testing into primary care use cases, where the platform will be assessed across a broader range of clinical topics and physician information needs. The expanded evaluation includes Spanish-language clinical content optimized for the Mexican healthcare environment. Mexico represents one of the largest healthcare markets in Latin America, creating a significant opportunity to evaluate AI-enabled access to trusted medical evidence at scale. The expansion of the evaluation program into primary care is intended to provide additional insight into platform performance, content coverage, usability, and future development opportunities. Phase 1 rheumatology testing was conducted under the guidance of Dr. Ruy Carrasco, Chief Medical Information Officer of Skye Salud and Brand Engagement Network Board Member. The evaluation focused on assessing the platform's ability to generate accurate, cited responses grounded in trusted medical evidence sources. The initial pilot within the domain of Rheumatology served as a critical baseline to validate the platform's response architecture, specifically concerning clinical rigor and evidence tractability. Extending this evaluation framework into Primary Care allows for the stress-testing of performance metrics across a more heterogeneous spectrum of clinical presentations. This expansion will be executed without compromising the stringent evidence thresholds or the source transparency protocols established during the foundational Phase 1 testing. The Phase 2 primary care evaluation serves a dual strategic purpose: assessing the platform's clinical coverage and evidence-support capabilities across broader care scenarios while generating actionable insights to inform future product development and commercialization planning. Subject to future evaluation results, regulatory considerations and commercial agreements, Brand Engagement Network, Grupo Skye, KNOBLOCH Information Group and other healthcare ecosystem participants may explore opportunities to broaden clinical coverage, expand Spanish-language medical content and evaluate potential future applications of the platform within healthcare settings across Mexico and Latin America.

U.S. IT Consulting Industry Analysis

Industry Valuation and Performance

Industry Comparison

Top Stock Gainers and Losers

Latest News

Accenture Falls Over 50% as Earnings Miss and AI Disruption Delay Major Deals

International Business Machines Corporation(NYSE:IBM) dropped from Russell 1000 Value-Defensive Index

BigBear.ai Holdings, Inc.(NYSE:BBAI) dropped from Russell 3000E Growth Benchmark

CSP Inc.(NasdaqGM:CSPI) dropped from Russell 3000E Value Benchmark

Gartner, Inc.(NYSE:IT) dropped from Russell 1000 Growth-Defensive Index

DXC Technology Company(NYSE:DXC) dropped from Russell Midcap Value Benchmark

EPAM Systems, Inc.(NYSE:EPAM) dropped from Russell 1000 Value-Defensive Index

Cognizant Unveils Major AI Integrations and Expands Partnerships for Neuro AI Growth

Investor sentiment deteriorates as stock falls 17%

EFOR: Tougher IT Services Demand Will Likely Pressure Shares Further

CINT: Higher 2026 Revenue Guidance Will Drive Rebound In Market Confidence

Kyndryl: Looks Mispriced After The Internal Control Selloff (Upgrade)

Investor sentiment deteriorates as stock falls 17%

Amdocs Chosen by Three Scandinavia for AI Customer Engagement Overhaul in Nordic Markets

Brand Engagement Network, Grupo Skye, and Knobloch Information Group Advance Skye Salud to Phase 2 Clinical Evaluation in Mexico

AIAI Holdings Corporation (NasdaqGM:AIAI) acquired Constellation Network, Inc.